Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.08 USD | -0.65% | -3.63% | -16.03% |
02:34pm | Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab | MT |
01:32pm | Bristol Myers: deadline set for subcutaneous Opdivo | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.05% | 87.9B | |
+38.43% | 705B | |
+32.30% | 583B | |
-2.86% | 364B | |
+21.05% | 332B | |
+6.39% | 291B | |
+15.92% | 238B | |
-3.48% | 210B | |
+10.50% | 209B | |
+9.70% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Names Christopher Boerner as Chair